About this trial
The aim of this study was to investigate the effects of enteral nutrition content on disease progression in sepsis patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Being diagnosed with sepsis and being able to receive enteral nutrition 24 hours after starting treatment in the intensive care unit
Disqualifiers
chronic liver disease, chronic renal failure, active cancer or parenteral nutrition
Trial population
Patients diagnosed with sepsis who were older than 18 years and receiving enteral nutrition and receiving treatment in the Intensive Care Unit of Mehmet Akif Inan Training and Research Hospital were included.
Trial design
Cohort
Prospective
Treatments tested in this trial
nutrition monitoring
Other interventionThere is no investigator intervention in the study. Patients' nutrition is recorded for one week from the beginning of the study.
Treatment groups
Trial outcomes
Primary outcomes
Change in Serum Glucose Level
Change in fasting blood glucose level (mg/dL) from baseline to Day 7.
Change in Serum Albumin Level
Change in serum albumin concentration (g/dL) from baseline to Day 7.
Change in Serum C-Reactive Protein (CRP) Level
Change in serum CRP level (mg/L) from baseline to Day 7.
Change in Hemoglobin Level
Change in hemoglobin concentration (g/dL) from baseline to Day 7.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.